M.D., Chief Clinical Officer, ADVI
Louis Jacques, M.D. is Chief Clinical Officer and a Senior Vice President at ADVI, a health care advisory services firm. He also serves on several institutional boards and advisory panels. Before joining ADVI in 2014, Dr. Jacques was the Director of the Coverage and Analysis Group (CAG) in the Centers for Medicare & Medicaid Services (CMS) from 2009 – 2014, where he managed Medicare fee for service coverage policy development on technologies as diverse as molecular diagnostic testing, implanted cardiac devices, advanced imaging, chemotherapeutics, wound care, and screening and preventive services. From 2004 – 2009 he was a division director within CAG, focusing on Part B drugs and diagnostic tests. Before joining CMS in 2003, was Associate Dean for Curriculum at Georgetown University School of Medicine; where he saw patients at the Lombardi Cancer Center in his practice of hospice and palliative medicine.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Advanced diagnostics plays a critical role in precision medicine, insuring that patients receive the most appropriate treatment. However, regulatory uncertainty as well as difficulties with reimbursement difficulty, create a challenging funding environment for innovation. This session’s discussion will focus on where the diagnostics industry is today as well as its outlook for the future.